Clinical Trials Browser

Phase 1 × Recruiting × Hyaluronoglucosaminidase × Clear all

NCT06622005 2025-04-16

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma